I. Sargiannidou

发表

Genetic mechanisms of peripheral nerve disease

M. Stavrou, I. Sargiannidou, Theodoulakis Christofi, 2020, Neuroscience Letters.

Gene Therapy for CMT Inherited Neuropathy

I. Sargiannidou, K. Kleopa, A. Kagiava, 2019, Muscle Gene Therapy.

Human oligodendrocytes express Cx31.3: Function and interactions with Cx32 mutants

R. Reynolds, A. Peinado, S. Scherer, 2008, Neurobiology of Disease.

A start codon CMT1X mutation associated with transient encephalomyelitis causes complete loss of Cx32

I. Sargiannidou, K. Kleopa, Gun-Ha Kim, 2015, neurogenetics.

Dysregulation of Blood-Brain Barrier and Exacerbated Inflammatory Response in Cx47-Deficient Mice after Induction of EAE

I. Sargiannidou, K. Kleopa, Filippos Stavropoulos, 2021, Pharmaceuticals.

Connexin32 Mutations Cause Loss of Function in Schwann Cells and Oligodendrocytes Leading to PNS and CNS Myelination Defects

K. Kyriacou, A. Hadjisavvas, S. Scherer, 2009, The Journal of Neuroscience.

Differential modulation of the juxtaparanodal complex in Multiple Sclerosis

I. Sargiannidou, K. Kleopa, D. Karagogeos, 2015, Molecular and Cellular Neuroscience.

Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies

M. Stavrou, I. Sargiannidou, K. Kleopa, 2021, International journal of molecular sciences.

Gene delivery targeted to oligodendrocytes using a lentiviral vector

A. Gritti, I. Sargiannidou, K. Kleopa, 2014, The journal of gene medicine.

Gene therapy approaches targeting Schwann cells for demyelinating neuropathies

I. Sargiannidou, K. Kleopa, A. Kagiava, 2019, Brain Research.

Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis

R. Reynolds, A. Hadjisavvas, I. Sargiannidou, 2012, Glia.

Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination

I. Sargiannidou, K. Kleopa, C. Karaiskos, 2018, Glia.

Intrathecal gene therapy in mouse models expressing CMT1X mutations

I. Sargiannidou, K. Kleopa, A. Kagiava, 2018, Human molecular genetics.

Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease

I. Sargiannidou, K. Kleopa, A. Kagiava, 2016, Acta neuropathologica communications.

Connexins, gap junctions and peripheral neuropathy

I. Sargiannidou, K. Kleopa, 2015, Neuroscience Letters.

Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy

H. Zetterberg, I. Sargiannidou, K. Kleopa, 2019, Brain : a journal of neurology.

AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy

H. Zetterberg, R. Horvath, M. Stavrou, 2021, Gene Therapy.

Aberrant Mitochondrial Dynamics and Exacerbated Response to Neuroinflammation in a Novel Mouse Model of CMT2A

I. Sargiannidou, K. Kleopa, A. Kagiava, 2021, International journal of molecular sciences.

Golgi‐retained Cx32 mutants interfere with gene addition therapy for CMT1X

I. Sargiannidou, K. Kleopa, A. Kagiava, 2017, Human molecular genetics.

Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X.

H. Zetterberg, I. Sargiannidou, K. Kleopa, 2019, Human molecular genetics.

Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter

R. Reynolds, A. Hadjisavvas, I. Sargiannidou, 2012, Acta Neuropathologica.

Novel GJA1/Cx43 Variant Associated With Oculo-Dento-Digital Dysplasia Syndrome: Clinical Phenotype and Cellular Mechanisms

A. Hadjisavvas, I. Sargiannidou, K. Kleopa, 2021, Frontiers in Genetics.

Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy

G. Theophilidis, S. Scherer, I. Sargiannidou, 2016, Proceedings of the National Academy of Sciences.

Glial Gap Junction Pathology in the Spinal Cord of the 5xFAD Mouse Model of Early-Onset Alzheimer’s Disease

Andreas M. Koupparis, I. Sargiannidou, K. Kleopa, 2022, International journal of molecular sciences.

Impairment of learning and memory in TAG-1 deficient mice associated with shorter CNS internodes and disrupted juxtaparanodes

T. Panagiotaropoulos, I. Sargiannidou, K. Kleopa, 2008, Molecular and Cellular Neuroscience.

Connexin pathology in chronic multiple sclerosis and experimental autoimmune encephalomyelitis

I. Sargiannidou, K. Kleopa, K. Markoullis, 2013 .

Angiocidin inhibits breast cancer proliferation through activation of epidermal growth factor receptor and nuclear factor kappa (NF-ĸB).

I. Sargiannidou, G. Tuszynski, V. Rothman, 2011, Experimental and molecular pathology.

Cloning and characterization of angiocidin, a tumor cell binding protein for thrombospondin‐1

I. Sargiannidou, G. Tuszynski, V. Rothman, 2004, Journal of cellular biochemistry.

Molecular mechanisms of gap junction mutations in myelinating cells.

I. Sargiannidou, K. Kleopa, K. Markoullis, 2010, Histology and histopathology.

Gap Junction Disorders of Myelinating Cells

I. Sargiannidou, K. Kleopa, Jennifer L. Orthmann-Murphy, 2010, Reviews in the neurosciences.

Oligodendrocyte Gap Junction Loss and Disconnection From Reactive Astrocytes in Multiple Sclerosis Gray Matter

R. Reynolds, I. Sargiannidou, K. Kleopa, 2014, Journal of neuropathology and experimental neurology.

Altered Expression of Glial Gap Junction Proteins Cx43, Cx30, and Cx47 in the 5XFAD Model of Alzheimer’s Disease

I. Sargiannidou, K. Kleopa, S. Papacostas, 2020, Frontiers in Neuroscience.

Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model

M. Klugmann, I. Sargiannidou, K. Kleopa, 2017, Brain : a journal of neurology.

Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis.

I. Sargiannidou, G. Tuszynski, Cuie Qiu, 2004, Seminars in thrombosis and hemostasis.

Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery

I. Sargiannidou, K. Kleopa, A. Kagiava, 2021, Scientific Reports.

Intraneural GJB1 gene delivery improves nerve pathology in a model of X‐linked Charcot–Marie–Tooth disease

S. Scherer, I. Sargiannidou, K. Kleopa, 2015, Annals of neurology.

Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer’s Disease

G. Spyrou, I. Sargiannidou, K. Savva, 2023, Life.

Axonal Pathology Precedes Demyelination in a Mouse Model of X-Linked Demyelinating/Type I Charcot-Marie Tooth Neuropathy

K. Kyriacou, S. Scherer, I. Sargiannidou, 2010, Journal of neuropathology and experimental neurology.

Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease

I. Sargiannidou, K. Kleopa, A. Kagiava, 2016, Acta neuropathologica communications.

Charcot–Marie–Tooth neuropathies: Current gene therapy advances and the route toward translation

I. Sargiannidou, K. Kleopa, A. Kagiava, 2023, Journal of the peripheral nervous system : JPNS.

Oxaliplatin-induced neurotoxicity is mediated through gap junction channels and hemichannels and can be prevented by octanol

K. Kyriacou, G. Theophilidis, I. Sargiannidou, 2015, Neuropharmacology.

Transgenic replacement of Cx32 in gap junction-deficient oligodendrocytes rescues the phenotype of a hypomyelinating leukodystrophy model.

I. Sargiannidou, K. Kleopa, A. Kagiava, 2015, Human molecular genetics.

The Role of Thrombospondin-1 in Tumor Progression

I. Sargiannidou, G. Tuszynski, Jing Zhou, 2001, Experimental biology and medicine.

A start codon CMT1X mutation associated with transient encephalomyelitis causes complete loss of Cx32

I. Sargiannidou, K. Kleopa, Gun-Ha Kim, 2015, neurogenetics.

Gene replacement therapy in two Golgi-retained CMT1X mutants before and after the onset of demyelinating neuropathy

I. Sargiannidou, K. Kleopa, A. Kagiava, 2023, Molecular therapy. Methods & clinical development.

Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro

I. Sargiannidou, K. Kleopa, R. Baloh, 2023, Journal of the peripheral nervous system.

Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy

H. Zetterberg, I. Sargiannidou, K. Kleopa, 2019, Brain : a journal of neurology.

Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis

I. Sargiannidou, K. Kleopa, Styliani Theophanous, 2024, International journal of molecular sciences.

The role of adhesive proteins in the hematogenous spread of cancer.

I. Sargiannidou, G. Tuszynski, J. Zhou, 2000, In vivo.